These benefits, together with a previous report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 support the idea of concentrating on ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-connected Conditions. Disclaimer: The above mentioned is https://jeffj516xdi0.theideasblog.com/profile